JSVZX
Price
$25.70
Change
+$0.18 (+0.71%)
Updated
Sep 26 closing price
Net Assets
1.24B
UBVVX
Price
$86.07
Change
+$0.94 (+1.10%)
Updated
Sep 26 closing price
Net Assets
9.74B
Interact to see
Advertisement

JSVZX vs UBVVX

Header iconJSVZX vs UBVVX Comparison
Open Charts JSVZX vs UBVVXBanner chart's image
JPMorgan Small Cap Value R2
Price$25.70
Change+$0.18 (+0.71%)
VolumeN/A
Net Assets1.24B
Undiscovered Managers Behavioral Val R5
Price$86.07
Change+$0.94 (+1.10%)
VolumeN/A
Net Assets9.74B
JSVZX vs UBVVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JSVZX vs. UBVVX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSVZX is a StrongBuy and UBVVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.74B vs. JSVZX (1.24B). UBVVX pays higher dividends than JSVZX: UBVVX (1.77) vs JSVZX (0.61). JSVZX was incepted earlier than UBVVX: JSVZX (17 years) vs UBVVX (9 years). JSVZX (1.60) is less costly to investors than UBVVX (0.95). JSVZX is a more actively managed with annual turnover of: 61.00 vs. UBVVX (27.00). JSVZX (0) and UBVVX (0) have matching initial minimum investment requirements. UBVVX annual gain was more profitable for investors over the last year : 0.31 vs. JSVZX (0.00). UBVVX return over 5 years is better than : 107.51 vs. JSVZX (46.11).
JSVZXUBVVXJSVZX / UBVVX
Total Expense Ratio1.490.90166%
Annual Report Gross Expense Ratio1.600.95168%
Fund Existence17 years9 years-
Gain YTD6.6922.489269%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B9.74B13%
Annual Yield % from dividends0.611.7734%
Returns for 1 year0.000.310%
Returns for 3 years20.3422.7589%
Returns for 5 years46.11107.5143%
Returns for 10 years15.72N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CANC27.270.54
+2.02%
Tema Oncology ETF
WCEO32.540.39
+1.21%
Hypatia Women CEO ETF
DTD83.720.58
+0.70%
WisdomTree US Total Dividend ETF
FINX33.430.13
+0.39%
Global X FinTech ETF
KSPY28.190.05
+0.18%
KraneShares Hedgeye Hedged Eq Idx ETF